3 Beaten-Down Stocks With GLP-1 Exposure to Buy and Hold
The first GLP-1 medicine was approved in the U.S. in 2005 for the treatment of type 2 diabetes.…
Eli Lilly and Novo Nordisk Are Fine — but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom
Demand for GLP-1 medicines is booming, as these drugs have proven highly effective at treating diabetes, obesity, and…